Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Teva Pharmaceutical Industries (Teva) has reported that several of its subsidiaries in the US have reached a settlement in principle to resolve claims brought by Ven-A-Care of the Florida Keys, on behalf of the US, Texas, Florida, and California under federal and state False Claims Acts.
Subscribe to our email newsletter
Together with many other pharmaceutical manufacturers, Teva is named in numerous civil lawsuits that relate to drug price reporting by manufacturers in about 15 states. The cases, which are pending in federal and state courts, generally allege that the prices reported by pharmaceutical companies caused governments to pay inflated reimbursements for drugs under Medicaid or other programs. Teva denies the allegations.
Upon execution of definitive settlement documents and certain government and court approvals, the settlement will resolve a lawsuit relating to federal contributions to all state Medicaid programs and claims of Texas, Florida, and California relating to their Medicaid programs.
Additionally, the settlement is expected to eliminate the majority of the alleged damages asserted against Teva in the various drug pricing litigations.
Teva will record a charge of approximately $315m in its fourth quarter, 2009 results. The charge includes both the settlement in principle and a reserve for the remaining drug pricing lawsuits to which Teva is a party.